Patent assignee · US · COMPANY

Celegene Corporation

3Patents
0Active
3Granted
27Portfolio score

Filing activity: Sep 29, 1997 → May 24, 2001

Most-cited patents

PatentTitleAreaCited byStatus
US6635284B2 Delivery of multiple doses of medications Human Necessities 77 Expired
US6602887B2 Chronic, bolus administration of D-threo methylphenidate Chemistry; Metallurgy 16 Expired
US5922736A Chronic, bolus administration of D-threo methylphenidate Chemistry; Metallurgy 9 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.